Chemed (CHE) Short Interest Ratio & Short Volume → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free CHE Stock Alerts $572.21 -8.15 (-1.40%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Chemed Short Interest DataCurrent Short Volume436,700 sharesPrevious Short Volume451,600 sharesChange Vs. Previous Month-3.30%Dollar Volume Sold Short$268.57 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 15, 2024Outstanding Shares15,140,000 sharesFloat Size14,770,000 sharesShort Percent of Float2.96%Today's Trading Volume102,919 sharesAverage Trading Volume81,280 sharesToday's Volume Vs. Average127% Short Selling Chemed ? Sign up to receive the latest short interest report for Chemed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCHE Short Interest Over TimeCHE Days to Cover Over TimeCHE Percentage of Float Shorted Over Time Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> Chemed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024436,700 shares $268.57 million -3.3%3.0%5.5 $615.00 3/31/2024451,600 shares $289.90 million -4.4%3.1%5.7 $641.93 3/15/2024472,400 shares $305.88 million +1.7%3.2%5.9 $647.51 2/29/2024464,400 shares $291.10 million +5.3%3.2%5.9 $626.84 2/15/2024441,100 shares $258.18 million +2.9%3.0%5.7 $585.32 1/31/2024428,600 shares $253.91 million +1.4%2.9%5.7 $592.42 Get the Latest News and Ratings for CHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024422,500 shares $246.19 million -6.3%2.9%5.4 $582.69 12/31/2023450,900 shares $263.66 million -1.7%3.1%5.9 $584.75 12/15/2023458,600 shares $263.47 million +4.2%3.1%6 $574.51 11/30/2023440,100 shares $249.54 million +0.6%3.0%5.8 $567.00 11/15/2023437,400 shares $252.98 million -0.5%3.0%5.9 $578.38 10/31/2023439,600 shares $247.38 million -0.7%3.0%6.1 $562.74 10/15/2023442,700 shares $222.55 million +3.3%3.0%6.3 $502.71 9/30/2023428,600 shares $222.74 million -3.4%2.9%6.1 $519.70 9/15/2023443,600 shares $227.32 million -13.3%3.0%6.2 $512.45 8/31/2023511,700 shares $261.78 million -21.0%3.5%7.1 $511.58 8/15/2023648,000 shares $332.07 million +4.2%4.4%8.7 $512.46 7/31/2023622,000 shares $324.09 million -6.6%4.2%8.5 $521.04 7/15/2023666,200 shares $358.71 million +1.3%4.6%9.8 $538.44 6/30/2023658,000 shares $356.38 million +11.2%4.5%9.9 $541.61 6/15/2023591,500 shares $321.39 million +10.0%4.0%8.9 $543.35 5/31/2023537,800 shares $287.06 million +13.3%3.7%8.1 $533.77 5/15/2023474,700 shares $259.06 million +21.9%3.2%7 $545.74 4/30/2023389,300 shares $214.60 million -0.4%2.7%5.4 $551.25 4/15/2023390,700 shares $219.57 million -4.4%2.7%5.4 $561.99 3/31/2023408,800 shares $219.83 million -5.4%2.8%5.5 $537.75 3/15/2023432,300 shares $223.11 million -15.6%3.0%5.9 $516.09 2/28/2023512,000 shares $267.05 million +42.1%3.5%6.8 $521.58 2/15/2023360,200 shares $185.43 million +15.5%2.5%4.8 $514.81 1/31/2023311,800 shares $157.50 million +8.5%2.2%4.1 $505.14 1/15/2023287,400 shares $142.97 million -15.7%2.0%3.5 $497.45 12/30/2022341,000 shares $174.06 million +2.1%2.4%4 $510.43 12/15/2022334,100 shares $168.32 million -1.7%2.3%3.9 $503.79 11/30/2022339,800 shares $176.70 million -7.7%2.3%3.8 $520.00 11/15/2022368,100 shares $182.83 million +20.5%2.5%4.4 $496.68 10/31/2022305,500 shares $142.63 million +3.6%2.1%3.9 $466.87 10/15/2022294,900 shares $127.54 million +2.3%2.0%4.1 $432.50 9/30/2022288,300 shares $125.86 million +6.6%2.0%4.3 $436.56 9/15/2022270,500 shares $130.23 million +2.7%1.9%4.1 $481.44 8/31/2022263,400 shares $125.43 million -7.9%1.8%4.1 $476.19The new financial threat that could wipe out millions… (Ad)During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video CHE Short Interest - Frequently Asked Questions What is Chemed's current short interest? Short interest is the volume of Chemed shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 436,700 shares of CHE short. 2.96% of Chemed's shares are currently sold short. Learn More on Chemed's current short interest. What is a good short interest ratio for Chemed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CHE shares currently have a short interest ratio of 6.0. Learn More on Chemed's short interest ratio. Which institutional investors are shorting Chemed? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Chemed: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Chemed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.96% of Chemed's floating shares are currently sold short. Is Chemed's short interest increasing or decreasing? Chemed saw a decrease in short interest in April. As of April 15th, there was short interest totaling 436,700 shares, a decrease of 3.3% from the previous total of 451,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Chemed's float size? Chemed currently has issued a total of 15,140,000 shares. Some of Chemed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chemed currently has a public float of 14,770,000 shares. How does Chemed's short interest compare to its competitors? 2.96% of Chemed's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Chemed: Amedisys, Inc. (7.51%), Option Care Health, Inc. (2.51%), Viking Therapeutics, Inc. (10.11%), Roivant Sciences Ltd. (8.18%), Encompass Health Co. (2.23%), Henry Schein, Inc. (4.14%), Ascendis Pharma A/S (6.18%), Repligen Co. (8.85%), Legend Biotech Co. (6.04%), Cerevel Therapeutics Holdings, Inc. (9.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Chemed stock? Short selling CHE is an investing strategy that aims to generate trading profit from Chemed as its price is falling. CHE shares are trading down $7.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chemed? A short squeeze for Chemed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CHE, which in turn drives the price of the stock up even further. How often is Chemed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: AMED Short Squeeze OPCH Short Squeeze VKTX Short Squeeze ROIV Short Squeeze EHC Short Squeeze HSIC Short Squeeze ASND Short Squeeze RGEN Short Squeeze LEGN Short Squeeze CERE Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:CHE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press